Muller & Phipps FY26 Results: Net loss narrows 96% YoY to ₹3.13 lakh
- Standalone net loss narrows 96% YoY to ₹3.13 lakh; consolidated loss falls to ₹4.75 lakh
- Revenue drops 4.8% to ₹563.16 lakh amid decline in medicated preparations sales
- Commission income surges to ₹100.80 lakh, driving total revenue growth of 11.4%
- Operating cash flow turns positive at ₹12.50 lakh vs outflow of ₹41.78 lakh last year
- No dividend declared due to accumulated losses; negative equity stands at ₹206.41 lakh
*this image is generated using AI for illustrative purposes only.
Muller & Phipps India Limited reported a significant contraction in its net loss for the financial year ended March 31, 2026. The standalone net loss narrowed by 96% year-on-year to ₹3.13 lakh from ₹74.83 lakh in the previous fiscal. Consolidated results showed an even sharper improvement, with the group's net loss dropping to ₹4.75 lakh compared to ₹75.69 lakh in FY25.
Financial Performance
Revenue from operations declined slightly to ₹563.16 lakh in FY26, down from ₹591.60 lakh in FY25. This decrease was primarily due to a drop in sales of medicated preparations, which fell to ₹561.28 lakh from ₹577.68 lakh. Sales of cosmetics and toiletries also contracted sharply to ₹1.88 lakh from ₹13.92 lakh. Despite the revenue dip, total revenue rose to ₹690.75 lakh from ₹619.93 lakh, supported by a substantial increase in other income.
| Metric | FY26 (₹ Lakh) | FY25 (₹ Lakh) | Change |
|---|---|---|---|
| Revenue from Operations | 563.16 | 591.60 | -4.8% |
| Other Income | 127.59 | 28.33 | +350.4% |
| Total Revenue | 690.75 | 619.93 | +11.4% |
| Total Expenses | 693.88 | 694.76 | -0.1% |
| Net Profit / (Loss) | (3.13) | (74.83) | +95.8% |
What the Numbers Show
The dramatic reduction in losses was driven almost entirely by non-operating income rather than core business profitability. Commission income alone contributed ₹100.80 lakh to other income, a category that saw no such earnings in the previous year. This single line item accounted for roughly 79% of the total other income and more than offset the operational deficit. Employee benefit expenses rose to ₹250.99 lakh from ₹238.12 lakh, indicating rising fixed costs despite lower sales volumes. Travel and conveyance costs also increased significantly to ₹77.33 lakh from ₹60.85 lakh.
Balance Sheet and Cash Flow
The company reported positive cash flow from operating activities of ₹12.50 lakh in FY26, reversing a cash outflow of ₹41.78 lakh in the prior year. This improvement was aided by better management of sundry creditors and other liabilities, which provided ₹23.93 lakh in cash inflows. However, the balance sheet remains under pressure with a negative equity position. Total equity stood at negative ₹206.41 lakh as of March 31, 2026. Borrowings were reduced slightly to ₹76.12 lakh from ₹83.92 lakh, primarily consisting of unsecured loans from related parties.
Corporate Governance
The Board of Directors did not recommend any dividend for the year due to carried-forward losses. Mr. Raymond Simkins retires by rotation at the upcoming Annual General Meeting and offers himself for reappointment. The company has reappointed Shankarlal Jain & Associates LLP as statutory auditors for a second term of three years. The AGM is scheduled for September 28, 2026.
Historical Stock Returns for Muller & Phipps
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| 0.0% | 0.0% | -2.00% | -7.91% | 0.0% | 0.0% |
Will the significant commission income that drove the loss reduction be a recurring revenue stream, or was it a one-time event?
How does the company plan to address its negative equity position of ₹206.41 lakh given the continued operational losses?
What specific strategies are in place to reverse the decline in core medicated preparations sales and revive the cosmetics segment?
15
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
